This news release reports on a study showing an association between eating plant protein and lower risk of early menopause. Researchers evaluated data from the Nurses’ Health Study II, a large-scale effort to identify risk factors of disease in women. The study appeared in the Journal of American Epidemiology. A sub-headline allows that the effect is “modest” but the news release headline implies a cause-and-effect relationship that can’t be proven with one study based on observing a sample group of people, particularly when the group is self-reporting and subject to errors in recall.
We have some tips on ways to write headlines for diet and observational studies in general that avoid the suggestion of cause and effect.
Early menopause, also known as premature ovarian insufficiency, is a cause of infertility and has other negative health repercussions. While autoimmune diseases and genetics are sometimes to blame, most cases have no known trigger. In this study, the authors hypothesize that either some diets cause a build-up of arterial plaque that may reduce blood supply to the ovaries, or that soy-based diets protect ovarian function and slow the rate of follicle depletion. While this study suggests a potential dietary link, according to the authors, it remains to be seen whether the findings “can directly translate to premenopausal women.” In other words, it’s too soon to suggest young women eat more plant foods solely to protect their reproductive health, although there are other good reasons to add nuts and legumes to your diet.
Replacing animal products with plant foods wouldn’t significantly raise a person’s food budget and might actually save money.
The news release does the minimum in conveying the size of the link between diet and early menopause risk, saying women who consumed about 6.5 percent of their daily calories as vegetable protein had a 16 percent lower risk compared with women whose vegetable protein intake was approximately 4 percent of calories.
It further states: “For a woman with a 2,000 calorie per day diet, the authors explain, this is equal to three to four servings of such foods as enriched pasta, breakfast cereal, tofu and nuts, or about 32.5 grams a day.”
The release could have provided better perspective by giving some absolute numbers. With a 10 percent overall risk, a 16 percent reduction would amount to one or two women in every hundred.
It also could have helped readers interpret this quote from researchers: “Though relatively few women in our study consumed very high levels of vegetable protein and our power for analyses of more extreme intake levels was limited, women consuming 9 or more percent of their calories from vegetable protein had a hazard ratio of 0.41 (95 percent confidence interval = 0.19-0.88)” compared to those eating less than 4 percent.
In more understandable terms, women consuming 9 percent or more of the calories from vegetable protein developed early menopause at slightly less than half the rate of those getting less than 4 percent of their calories from vegetable protein.
The news release doesn’t discuss harms such as allergic reactions or other adverse effects from eating certain plant foods such as soy, wheat, and nuts. However, a discussion of harms doesn’t seem to be warranted since the news release does not advocate consumption of a specific foods, but rather suggests that a moderate increase in a range of plant foods might offer a benefit.
The news release explains in detail how the study was conducted, including the fact that it captured data from 2,041 women who experienced early menopause. But it doesn’t mention limitations with using self-reported data on dietary intake and age of menopause. Nor does it spell out that this is a single observational study, which can’t establish a causal relationship. Its final sentence saying researchers “suggest that more prospective studies of their findings are warranted, including studies that compare soy-based and non-soy vegetable proteins” amounts to too little, too late.
It’s also worth noting that the study includes only nurses, a subset of the population who may not be representative of all US women in their dietary patterns, thus making it difficult to draw general conclusions. For example, if a woman is at risk for early menopause because of chemotherapy, would this study be relevant for her? That’s unclear.
The release mentions that adjustments were made for certain variables (“confounders”) but theoretically, there would be many variables to consider that weren’t studied or adjusted for.
The news release doesn’t disease monger. It does state that early menopause, defined as the cessation of ovarian function before age 45, affects about 10 percent of women and is associated with higher risk of cardiovascular disease, osteoporosis and early cognitive decline as well as cutting short fertility. The study itself cites prevalence figures ranging from 5 to 10 percent. The news release could have included that range instead of going with the higher estimate.
The news release states that the study was supported by a grant from NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development. The researchers reported no conflicts.
There don’t seem to be any common strategies to prevent early menopause, but the news release could have delved into alternative potential causes such as autoimmune disease, genetics and cancer treatment.
Availability isn’t an issue. Adding vegetable protein to your diet in the modest amounts involved in this study is a fairly easy thing to do. A completely vegetarian diet is more challenging, but that’s not what the study suggests.
The release states: “Few studies have evaluated how protein intake is associated with menopause timing, (researchers) add, and to their knowledge this is the first to look specifically at early menopause.” A researcher is also quoted saying, “A better understanding of how dietary vegetable protein intake is associated with ovarian aging may identify ways for women to modify their risk of early onset menopause and associated health conditions.”
We commend the use of the word “modest” in the sub-headline to describe the effect of vegetable protein on early menopause risk. But the news release makes missteps including the use of the word “significant,” which might confuse some readers into believing the study shows a significant impact on early menopause risk when in fact it appears to mean the data is statistically significant, or reliable.
Frequently, news reports about studies showing an association between food and health outcomes imply a causal relationship, which can’t be shown with a single study based on observations. This one does just that when it states in the headline and the lead that eating more vegetable protein “may protect against early menopause.” We wish news releases based on observational studies would be more upfront about limitations when describing the research. Adding a descriptor such as “these are useful findings that need further study” would help.
The following quote also may leave readers with the idea that they can control their reproductive future based on this study’s results: “A better understanding of how dietary vegetable protein intake is associated with ovarian aging may identify ways for women to modify their risk of early onset menopause and associated health conditions.” Giving women better information so they can control of their health is a laudable goal, but this study doesn’t achieve that, and the news release should have made that more clear.
Further, the lead confuses matters by citing “foods such as whole grains, soy and tofu” when the foods that accounted for the greatest variation in vegetable protein intake in the study were pasta, dark bread, and cereal.
This news release from the North American Menopause Society makes a brief study of fennel…
This news release looks at a program to introduce a quality improvement initiative aimed at…
This news release from the FDA announces the agency’s approval of a new drug, dupilumab…
Systematic, Criteria-Driven
We will not display your name or e-mail address on the site, nor will we share your e-mail address with any third parties.
Thank you for joining the HealthNewsReview.org mailing list. It’s a good way for you to stay up-to-date on what we’ve published, even if you forget to come to our website every day or every week.
-Gary Schwitzer, Publisher, HealthNewsReview.org
By submitting this form, you are granting: HealthNewsReview.org, University of Minnesota , Minneapolis, MN, 55455, United States, https://www.healthnewsreview.org permission to email you. You may unsubscribe via the link found at the bottom of every email. Emails are serviced by Mailchimp. (See their Email Privacy Policy for details.)
This news release from the North American Menopause Society makes a brief study of fennel…
This news release looks at a program to introduce a quality improvement initiative aimed at…
This news release from the FDA announces the agency’s approval of a new drug, dupilumab…
Health misinformation in the news: Where does it start? https://t.co/wEOa4UYCAY via @kevinmd
This is sad. One of the few outlets that corrected hype and took on topics no one else would. https://t.co/5PDjjQXtXG
News outlets focus on one dramatic outcome. But did researchers omit data from hundreds in clinical trial? see @VinayPrasadMD comments https://t.co/TouVpZ0oSW via @mlmjoyce
Comments
We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.
We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like
This news release from the North American Menopause Society makes a brief study of fennel…
This news release looks at a program to introduce a quality improvement initiative aimed at…
This news release from the FDA announces the agency’s approval of a new drug, dupilumab…